Natalie Moshayedi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma”.

Phase I trial of Bermekimab with nanoliposomal irinotecan and 5-fluorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-19401-3

N/A

0.587DataRank · unranked

10 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more

Author Correction: Phase I trial of Bermekimab with nanoliposomal irinotecan and 5‑fuorouracil/folinic acid in advanced pancreatic ductal adenocarcinoma

Scientific Reports(2022)10.1038/s41598-022-23619-6

N/A

0DataRank · unranked

1 citations

Shant Thomassian, Sungjin Kim, Gillian Gresham, Natalie Moshayedi, Jason Ye +9 more